184 related articles for article (PubMed ID: 36867377)
21. Low-grade inflammation in survivors of childhood cancer and testicular cancer and its association with hypogonadism and metabolic risk factors.
Ekedahl H; Isaksson S; Ståhl O; Bogefors K; Romerius P; Eberhard J; Giwercman A
BMC Cancer; 2022 Feb; 22(1):157. PubMed ID: 35135482
[TBL] [Abstract][Full Text] [Related]
22. Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors.
Hjelle LV; Bremnes RM; Gundersen POM; Sprauten M; Brydøy M; Tandstad T; Wilsgaard T; Fosså SD; Oldenburg J; Haugnes HS
Urol Oncol; 2016 Nov; 34(11):487.e13-487.e20. PubMed ID: 27523611
[TBL] [Abstract][Full Text] [Related]
23. The cardiac impact of cisplatin-based chemotherapy in survivors of testicular cancer: a 30-year follow-up.
Bjerring AW; Fosså SD; Haugnes HS; Nome R; Stokke TM; Haugaa KH; Kiserud CE; Edvardsen T; Sarvari SI
Eur Heart J Cardiovasc Imaging; 2021 Mar; 22(4):443-450. PubMed ID: 33152065
[TBL] [Abstract][Full Text] [Related]
24. Testicular Cancer Survivorship.
Fung C; Dinh PC; Fossa SD; Travis LB
J Natl Compr Canc Netw; 2019 Dec; 17(12):1557-1568. PubMed ID: 31805527
[TBL] [Abstract][Full Text] [Related]
25. Hypogonadism and fertility issues following primary treatment for testicular cancer.
Oldenburg J
Urol Oncol; 2015 Sep; 33(9):407-12. PubMed ID: 25736189
[TBL] [Abstract][Full Text] [Related]
26. Prognostic interactions between cardiovascular risk factors.
Vishram JK
Dan Med J; 2014 Jul; 61(7):B4892. PubMed ID: 25123126
[TBL] [Abstract][Full Text] [Related]
27. Vasectomy and subsequent cardiovascular disease in US physicians.
Manson JE; Ridker PM; Spelsberg A; Ajani U; Lotufo PA; Hennekens CH
Contraception; 1999 Mar; 59(3):181-6. PubMed ID: 10382081
[TBL] [Abstract][Full Text] [Related]
28. Cardiovascular disease risk factors and preventive practices among adults--United States, 1994: a behavioral risk factor atlas. Behavioral Risk Factor Surveillance System State Coordinators.
Hahn RA; Heath GW; Chang MH
MMWR CDC Surveill Summ; 1998 Dec; 47(5):35-69. PubMed ID: 9859955
[TBL] [Abstract][Full Text] [Related]
29. Metabolic Dyslipidemia and Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Findings From the Look AHEAD Study.
Kaze AD; Santhanam P; Musani SK; Ahima R; Echouffo-Tcheugui JB
J Am Heart Assoc; 2021 Apr; 10(7):e016947. PubMed ID: 33728932
[TBL] [Abstract][Full Text] [Related]
30. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort.
Guembe MJ; Fernandez-Lazaro CI; Sayon-Orea C; Toledo E; Moreno-Iribas C;
Cardiovasc Diabetol; 2020 Nov; 19(1):195. PubMed ID: 33222691
[TBL] [Abstract][Full Text] [Related]
31. Testicular cancer survivorship: research strategies and recommendations.
Travis LB; Beard C; Allan JM; Dahl AA; Feldman DR; Oldenburg J; Daugaard G; Kelly JL; Dolan ME; Hannigan R; Constine LS; Oeffinger KC; Okunieff P; Armstrong G; Wiljer D; Miller RC; Gietema JA; van Leeuwen FE; Williams JP; Nichols CR; Einhorn LH; Fossa SD
J Natl Cancer Inst; 2010 Aug; 102(15):1114-30. PubMed ID: 20585105
[TBL] [Abstract][Full Text] [Related]
32. Pathophysiology and therapeutics of cardiovascular disease in metabolic syndrome.
Wang Y; Yu Q; Chen Y; Cao F
Curr Pharm Des; 2013; 19(27):4799-805. PubMed ID: 23323622
[TBL] [Abstract][Full Text] [Related]
33. Risk of low bone mineral density in testicular germ cell cancer survivors: association with hypogonadism and treatment modality.
Isaksson S; Bogefors K; Åkesson K; Egund L; Bobjer J; Leijonhufvud I; Giwercman A
Andrology; 2017 Sep; 5(5):898-904. PubMed ID: 28591464
[TBL] [Abstract][Full Text] [Related]
34. Hemodynamic responses to a community-based Tai Chi exercise intervention in ethnic Chinese adults with cardiovascular disease risk factors.
Taylor-Piliae RE; Haskell WL; Froelicher ES
Eur J Cardiovasc Nurs; 2006 Jun; 5(2):165-74. PubMed ID: 16314148
[TBL] [Abstract][Full Text] [Related]
35. Metabolic syndrome: cardiovascular risk assessment and management.
Wong ND
Am J Cardiovasc Drugs; 2007; 7(4):259-72. PubMed ID: 17696567
[TBL] [Abstract][Full Text] [Related]
36. Sleep-time ambulatory blood pressure as a prognostic marker of vascular and other risks and therapeutic target for prevention by hypertension chronotherapy: Rationale and design of the Hygia Project.
Hermida RC
Chronobiol Int; 2016; 33(7):906-36. PubMed ID: 27221952
[TBL] [Abstract][Full Text] [Related]
37. Treatment-related differences in cardiovascular risk factors in long-term survivors of testicular cancer.
Wethal T; Kjekshus J; Røislien J; Ueland T; Andreassen AK; Wergeland R; Aukrust P; Fosså SD
J Cancer Surviv; 2007 Mar; 1(1):8-16. PubMed ID: 18648940
[TBL] [Abstract][Full Text] [Related]
38. Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study.
Kerns SL; Fung C; Monahan PO; Ardeshir-Rouhani-Fard S; Abu Zaid MI; Williams AM; Stump TE; Sesso HD; Feldman DR; Hamilton RJ; Vaughn DJ; Beard C; Huddart RA; Kim J; Kollmannsberger C; Sahasrabudhe DM; Cook R; Fossa SD; Einhorn LH; Travis LB;
J Clin Oncol; 2018 May; 36(15):1505-1512. PubMed ID: 29617189
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
